* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IPI Legacy Liquidation Co's EV-to-EBIT
For the Biotechnology subindustry, IPI Legacy Liquidation Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IPI Legacy Liquidation Co's EV-to-EBIT Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IPI Legacy Liquidation Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where IPI Legacy Liquidation Co's EV-to-EBIT falls into.
IPI Legacy Liquidation Co's current Enterprise Value is $114.92 Mil.
IPI Legacy Liquidation Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-70.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPI Legacy Liquidation Co (OTCPK:IMPLQ) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
IPI Legacy Liquidation Co's Enterprise Value for the quarter that ended in Sep. 2023 was $124.77 Mil.
IPI Legacy Liquidation Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-70.11 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPI Legacy Liquidation Co EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of IPI Legacy Liquidation Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
IPI Legacy Liquidation Co (IPI Legacy Liquidation Co) Business Description
Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IMPLQ has been successfully added to your 